Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
OxyCon Returns: The Flagship Web Scraping Conference Opens 2025 Registration
-
A comparative sNPWT study of 10,000+ C-sections shows PICO™ sNPWT reduces complications and cuts healthcare costs by $728,000 per 1,000 patients
-
Michelin | Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital
-
Absorb Recognized as a Global Leader in Learning Technology by Fosway, Talented Learning and G2 in 2025
-
WeRide Accelerates Robotaxi Mass Commercialization with 8 Autonomous 24/7 Routes in Central Guangzhou
-
Waterfall Network Augments Web3 Tools with Cascadify and The Lamb
-
Avis Budget Group Announces Intention to Offer $500 Million of Senior Notes
-
Avis Budget Group Announces Intention to Offer $500 Million of Senior Notes
-
Glass House Brands and LEEF Announce MSA for The Leaf El Paseo Dispensary and Off-Take Agreement
-
Angola Entry via Strategic Partnership with Corcel plc Investment in KON-16 Onshore Kwanza Basin
-
Arabsat selects Telesat Lightspeed Low Earth Orbit (LEO) services for its multi-orbit connectivity portfolio
-
Advanced Flower Capital Inc. Announces Financial Results for the First Quarter 2025
-
Emergent BioSolutions to Participate in Upcoming Investor Conferences
-
Introduction to UXUY Protocol
-
Pony AI Inc. Announces Voluntary Extended Lock-Ups by Founders
-
Bombardier Announces Launch of US$500 million New Issuance of Senior Notes due 2033 to retire US$500 million of its Senior Notes due 2027
-
Stallion Uranium Announces Failure to File Cease Trade Order
-
Erdene Announces Q1 2025 Results and Provides Bayan Khundii Project Update
-
Plus Therapeutics’ REYOBIQ™ Shows Clinical Benefit and Safety in the ReSPECT-LM Clinical Trial for Patients with Leptomeningeal Metastases (LM)
-
Inozyme Pharma Reports First Quarter 2025 Financial Results and Provides Business Highlights
-
Altimmune to Participate at Two Upcoming Investor Conferences
-
LAVA Reports First Quarter 2025 Financial Results, Provides Business Update
-
Quoin Pharmaceuticals Announces Initial Positive Clinical Data for QRX003 from Pediatric Peeling Skin Syndrome Study
-
Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder
-
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease on May 28, 2025
-
Highland Copper Announces Completion of Copperwood Metallurgical Drilling and Continued Progress on Detailed Engineering
-
Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
Moleculin Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
nCino Announces Timing of its First Quarter Fiscal Year 2026 Financial Results Conference Call
-
Abeona Therapeutics® and Lurie Children's Open First Center for ZEVASKYNTM Gene Therapy to Treat Wounds in Painful Skin Disorder
-
Gain Therapeutics Reports Financial Results for First Quarter 2025 and Provides Corporate Update
-
PDS Biotech Reports First Quarter 2025 Financial Results and Provides Clinical Programs and Corporate Update
-
Anavex Life Sciences to Participate at Upcoming Healthcare Conferences
-
Creative Realities Reports Fiscal 2025 First Quarter Results
-
Pyxis Oncology to Participate in Two Upcoming Investor Conferences
-
Nexxen Reports First Quarter 2025 Financial Results
-
PussFi Launches $PUSS: Turning Memes into Real-Utility Tokens!
-
Kornit Digital Reports First Quarter 2025 Results
-
Crown Crafts Announces Quarterly Cash Dividend
-
Coppernico Confirms Large-Scale Copper Skarn System and Expands Pipeline of Priority Targets at Sombrero
-
Unicycive Therapeutics Announces First Quarter 2025 Financial Results and Provides Business Update
-
Peter Lambrinakos, O.O.M., CPP, Joins Draganfly’s Public Safety Advisory Board, Strengthening Canadian Leadership in Public Safety
-
Form 8.3 - [Alpha Group International PLC (GB)]
-
New Storage Facilities Under StorageMart and Manhattan Mini Storage Third Party Management in Q1 2025
-
Calian Reports Results for the Second Quarter
-
Net Asset Value(s)
-
Pet Valu Celebrates 40th Anniversary of Dog Guides’ Fundraising Walk
-
Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
-
LeddarTech Announces the Launch of LeddarSim: Next Leap in Realistic Advanced Driver Assistance Systems (ADAS) and Autonomous Driving (AD) Simulation
-
Pasithea Therapeutics Announces Initiation of Phase 1/1B Study of PAS-004 in Adult NF1 Patients and Activation of First Clinical Trial Site
